Hudson Bay Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.92M	Buy	445,506 +375,506	+536%	+$8.97M	0.06%	317
2025 Q4	$1.87M	Sell	70,000 -300	-0.4%	-$7.17K	0.01%	724
2025 Q3	$1.5M	Sell	70,300 -119,700	-63%	-$2.83M	0.01%	794
2025 Q2	$4.1M	Sell	190,000 -120,950	-39%	-$2.25M	0.03%	598
2025 Q1	$5.16M	Buy	310,950 +45,950	+17%	+$835K	0.03%	586
2024 Q4	$4.86M	Sell	265,000 -110,000	-29%	-$1.78M	0.03%	510
2024 Q3	$5.77M	Sell	375,000 -12,500	-3%	-$209K	0.04%	389
2024 Q2	$6.3M	Buy	387,500 +162,500	+72%	+$2.62M	0.05%	338
2024 Q1	$4.16M	Buy	+225,000	New	+$5.57M	0.04%	337
2023 Q2	–	Sell	-50,000	Closed	-$941K	–	839
2023 Q1	$941K	Sell	50,000 -150,000	-75%	-$2.86M	0.01%	597
2022 Q4	$3.18M	Buy	200,000 +25,000	+14%	+$391K	0.04%	487
2022 Q3	$2.86M	Sell	175,000 -105,000	-38%	-$1.7M	0.03%	628
2022 Q2	$3.94M	Buy	280,000 +260,000	+1,300%	+$4.85M	0.04%	539
2022 Q1	$484K	Sell	20,000 -25,000	-56%	-$605K	0.01%	882
2021 Q4	$1.05M	Sell	45,000 -181,000	-80%	-$3.64M	0.01%	785
2021 Q3	$3.75M	Buy	226,000 +166,000	+277%	+$3.2M	0.05%	456
2021 Q2	$1.46M	Buy	60,000 +30,000	+100%	+$677K	0.02%	671
2021 Q1	$774K	Buy	+30,000	New	+$1.32M	0.01%	705
2020 Q4	–	Sell	-30,000	Closed	-$1.24M	–	582
2020 Q3	$1.24M	Buy	+30,000	New	+$1.3M	0.02%	402
2020 Q2	–	Hold	0	–	–	–	489
2019 Q4	–	Hold	0	–	–	–	421
2019 Q3	–	Sell	-15,000	Closed	-$455K	–	396
2019 Q2	$401K	Hold	15,000	–	–	0.01%	358
2019 Q1	$403K	Hold	15,000	–	–	0.01%	620
2018 Q4	$243K	Sell	15,000 -25,000	-63%	-$485K	0.01%	729
2018 Q3	$830K	Hold	40,000	–	–	0.02%	594
2018 Q2	$611K	Buy	+40,000	New	+$713K	0.02%	685
2017 Q2	–	Sell	-80,000	Closed	-$2.75M	–	517
2017 Q1	$2.75M	Buy	+80,000	New	+$2.82M	0.1%	394